¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
8/17 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2024-08-13
Á¶È¸¼ö
64


¾È³çÇϼ¼¿ä. À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.


Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº ÀÛ³â Nature microbiology ¿¡ ÃâÆǵÈ
'Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2' ÀÔ´Ï´Ù.

SARS-CoV-2 variant ´Â mRNA-1273 ¹× BNT162b2¿Í °°Àº wuhan-1 ¹ÙÀÌ·¯½º¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¹é½Å¿¡ ÀÇÇÑ ÁßÈ­È°¼ºÀÌ ¶³¾îÁü¿¡µµ ºÒ±¸ÇÏ°í ¿©ÀüÈ÷ ÁßÁõ Áúȯ°ú »ç¸ÁÀ¸·ÎºÎÅÍ protection È¿°ú°¡ ÀÖ½À´Ï´Ù.
ÀÌ´Â protection ¿¡ ÁßÈ­Ç×ü°¡ ¾Æ´Ñ ´Ù¸¥ ¸é¿ª ¸ÞÄ¿´ÏÁòÀÌ °ü¿©ÇÏ°í ÀÖÀ½À» ³ªÅ¸³À´Ï´Ù.
¹é½ÅÀ¸·Î À¯µµµÈ Ç×ü´Â FcγR¿Í °áÇÕÇÏ¿© SARS-CoV-2 °¨¿° ¼¼Æ÷¿¡ phagocytosis, lysis µî ÀÇ ±â´ÉÀ» º¸ÀÌÁö¸¸, protection ¿¡ ÀÖ¾î Fc effector function ÀÇ ¿ªÇÒÀº ¾ÆÁ÷ ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù.
ÀÌ ³í¹®¿¡¼­´Â WT ¹× FcγR KO ¸¶¿ì½º¸¦ ÀÌ¿ëÇÏ¿© Fc-FcγR »óÈ£ÀÛ¿ë°ú alveolar macrophage °¡ ¿À¹ÌÅ©·ÐÀ» Æ÷ÇÔÇÑ SARS-CoV-2 variant¿¡ ´ëÇÑ ¹é½Å À¯µµ Ç×ü º¸È£¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ» È®ÀÎÇß½À´Ï´Ù.

systems serology ºÐ¼®¹ý¿¡¼­ ÁÖ¿äÇÏ°Ô È®ÀÎÇÏ´Â Fc effector function ÀÌ ½ÇÁ¦·Î protection ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áö¿¡ ´ëÇÑ ±Ù°Å¸¦ Á¦°øÇÏ´Â ³í¹®À¸·Î °ü·Ã °øºÎ¸¦ À§ÇØ ¼±Á¤Çß½À´Ï´Ù.


³í¹® »çÀÌÆ®: https://www.nature.com/articles/s41564-023-01359-1
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
8/17 ¹ßÇ¥ ³í¹® ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ¹ßÇ¥ÀÚ¿µÁø ÀÔ´Ï´Ù. Á¦°¡¹ßÇ¥ÇÒ ³í¹®Àº 2023³â Science advances ¿¡ ÃâÆÇµÈ "JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma" ÀÔ´Ï´Ù. ILC2´Â type 2 cytokineÀ» ÁÖ¿äÇÏ°Ô »ý¼ºÇϸç õ½Ä ¹ß»ý¿¡ ±â¿©ÇÏ´Â ¸é¿ª¼¼Æ÷ÀÔ´Ï´Ù. õ½Ä ȯ..
ÀÌÀü±Û
8/10 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹ø ÁÖ ¹ßÇ¥ÀÚ ¿äÇÑÀÔ´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2022³â Immunity¿¡ ÃâÆÇµÈ ‘Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication’ ÀÔ´Ï´Ù. Conventional dendritic cell (cDC)´Â cDC1°ú cDC2·Î ³ª´µ..